These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 5924286)

  • 41. Studies of androgen production by the rat: testosterone and androstenedione content of blood.
    Bardin CW; Peterson RE
    Endocrinology; 1967 Jan; 80(1):38-44. PubMed ID: 6067592
    [No Abstract]   [Full Text] [Related]  

  • 42. Effect of leuprolide and dexamethasone on hair growth and hormone levels in hirsute women: the relative importance of the ovary and the adrenal in the pathogenesis of hirsutism.
    Rittmaster RS; Thompson DL
    J Clin Endocrinol Metab; 1990 Apr; 70(4):1096-102. PubMed ID: 2156885
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Inhibition of basal and adrenocorticotropin-stimulated plasma levels of adrenal androgens after treatment with an antiandrogen in castrated patients with prostatic cancer.
    Bélanger A; Dupont A; Labrie F
    J Clin Endocrinol Metab; 1984 Sep; 59(3):422-6. PubMed ID: 6086697
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Testosterone, androstenedione and dehydroepiandrosterone in plasma during pregnancy and at delivery: concentration and protein binding.
    Rivarola MA; Forest MG; Migeon CJ
    J Clin Endocrinol Metab; 1968 Jan; 28(1):34-40. PubMed ID: 4229673
    [No Abstract]   [Full Text] [Related]  

  • 45. Androgen levels during adjuvant endocrine therapy in postmenopausal breast cancer patients.
    Baumgart J; Nilsson K; Stavreus Evers A; Kunovac Kallak T; Kushnir MM; Bergquist J; Sundström Poromaa I
    Climacteric; 2014 Feb; 17(1):48-54. PubMed ID: 23647561
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Paradoxical effects associated with supranormal urinary testosterone excretion in premenopausal women with breast cancer: increased risk of postmastectomy recurrence and higher remission rate after ovariectomy.
    Secreto G; Zumoff B
    Cancer Res; 1983 Jul; 43(7):3408-11. PubMed ID: 6850646
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Conversion of androgens to estrogens in cirrhosis of the liver.
    Gordon GG; Olivo J; Rafil F; Southren AL
    J Clin Endocrinol Metab; 1975 Jun; 40(6):1018-26. PubMed ID: 1133151
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Venous-arterial counter-current transfer of [3H]testosterone in the vascular pedicle of the sow ovary.
    Krzymowski T; Kotwica J; Stefańczyk S
    J Reprod Fertil; 1981 Mar; 61(2):317-23. PubMed ID: 7205778
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Methyl testosterone and surgical castration in the treatment of carcinoma of the breast.
    BOGER WP
    J Clin Endocrinol Metab; 1946 Jan; 6():88-98. PubMed ID: 21014410
    [No Abstract]   [Full Text] [Related]  

  • 50. Progesterone and androgens in cyst fluid and vein blood in the human ovary.
    Aakvaag A; Fylling P
    Acta Obstet Gynecol Scand; 1966; 45(S9):158-9. PubMed ID: 5958385
    [No Abstract]   [Full Text] [Related]  

  • 51. Breast cancer years after hysterectomy and bilateral ovariectomy and increased androgenic activity.
    Grattarola R; Secreto G
    Oncology; 1980; 37(1):37-40. PubMed ID: 7350554
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Urinary testosterone values in patients with ovarian metastases from breast cancer.
    Secreto G
    Tumori; 1977; 63(5):457-62. PubMed ID: 601875
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Testosterone levels in the plasma of normal women and patients with benign breast disease or with breast cancer.
    Wang DY; Hayward JL; Bulbrook RD
    Eur J Cancer (1965); 1966 Dec; 2(4):373-6. PubMed ID: 5980828
    [No Abstract]   [Full Text] [Related]  

  • 54. Suprarenal-inferior mesenteric venous shunt for advanced carcinoma of the breast.
    Inokuchi K; Ikejiri T
    Arch Surg; 1966 Jun; 92(6):853-6. PubMed ID: 5933253
    [No Abstract]   [Full Text] [Related]  

  • 55. [OOPHORECTOMY IN ADVANCED BREAST CANCER].
    DE ANDRADE CF
    Arq Oncol; 1963; 5():153-68. PubMed ID: 14118617
    [No Abstract]   [Full Text] [Related]  

  • 56. [FURTHER STUDIES ON THE PRACTICAL SIGNIFICANCE OF THE EXAMINATION OF CELL NUCLEUS MORPHOLOGY IN BREAST CANCER].
    EHLERS PN; HIENZ H; HOCHBERG C; NURI M
    Chirurg; 1964 Jun; 35():271-2. PubMed ID: 14235380
    [No Abstract]   [Full Text] [Related]  

  • 57. [About the treatment of painful vertebral metastases from breast cancer by ovarian castration].
    FUNCK-BRENTANO P
    Mem Acad Chir (Paris); 1946; 72(4-6):65. PubMed ID: 21027430
    [No Abstract]   [Full Text] [Related]  

  • 58. Seasonal variation in plasma androgens and testosterone in the North American wild horse.
    Kirkpatrick JF; Wiesner L; Kenney RM; Ganjam VK; Turner JW
    J Endocrinol; 1977 Feb; 72(2):237-8. PubMed ID: 845536
    [No Abstract]   [Full Text] [Related]  

  • 59. [Ovariectomy in cancer of the breast as means for elimination of isolated organ metastases].
    SCHULTZ W
    Langenbecks Arch Klin Chir Ver Dtsch Z Chir; 1952-1953; 273():596-9. PubMed ID: 13045671
    [No Abstract]   [Full Text] [Related]  

  • 60. [Secretory activity of the mammary glands; sequellae of massive testosterone doses in women following castration].
    BOURG R
    Ann Endocrinol (Paris); 1950; 11(3):254-60. PubMed ID: 14811082
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.